Peter Salzmann | executive |
Robyn Karnauskas | analyst |
Derek Archila | analyst |
Yatin Suneja | analyst |
Danielle Brill | analyst |
Thomas Smith | analyst |
Brian Skorney | analyst |
Samuel Slutsky | analyst |
Douglas Tsao | analyst |
Good morning. My name is Daryl, and I will serve as your conference call operator.
[Operator Instructions] As a reminder, this call is being recorded.
Joining me on the call today will be Dr. Pete Salzmann, Chief Executive Officer of Immunovant.